Wang, et al. has disclosed that miR-661 is overexpressed in NSCLC tissues and cells and it accelerates NSCLC development via targeting RUNX3, which is consistent with findings of our research [25]. The gene discussed is RUNX3; the disease is non-small cell lung carcinoma.